
About Clyzo
Clyzo is a Healthcare company founded in 2018. Online platform for excipients procurement and pharmaceutical services. It operates in the Healthcare and Chemicals & Materials sectors. The company has 20 employees. Its Indian entity Pharmonix Biologicals Private Limited reported revenue of βΉ35.43 Cr. Clyzo offers products and services including Excipients and Value Added Services. Its focus areas include Pharmaceuticals, Excipients, Procurement Platform and Industrial Supplies.
Company details
Clyzo is recognized as an innovative platform that facilitates the searching, sampling, quoting, and purchasing of over 7500 pharmacopoeial excipients. Access to 1800 rare excipients across 40 categories is provided, along with regulatory documents in one place to simplify vendor qualifications. The platform supports drug development by offering tools for faster formulations and value-added services like REGpro and FINDezy. Testimonials indicate that procurement processes are streamlined, reducing time and effort for users.
- Employees 20
- SectorsHealthcareChemicals & Materials
- Emailβ’β’β’β’β’β’β’β’
- Website pharmonix.com
- Social LinkedIn X Instagram YouTube
- Legal Name Pharmonix Biologicals Private Limited
- Date of Incorporation 16 Mar, 2018
- Jurisdiction Thane, Maharashtra, India
- Indian entity revenue₹35.43 Cr
FY 2024 · +26% YoY
- Indian entity net profit₹6.30 Cr
FY 2024 · 18% margin
- Indian entity EBITDA₹8.81 Cr
FY 2024 · 25% margin
- Employee Count20
Associated legal entities of Clyzo
Clyzo operates through Pharmonix Biologicals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Pharmonix Biologicals Private Limited CIN U74999PN2018PTC175443 | Active | 16 Mar 2018 | Thane, Maharashtra | ₹35.4 Cr | 20 | 3 | View details |
Products & Services of Clyzo
Clyzo offers a comprehensive portfolio of products and services, including Excipients and Value Added Services.
A wide range of excipients is provided for pharma formulations, covering over 7500 SKUs across various categories and functions.
Services are offered to simplify procurement processes, including quotation generation and regulatory document handling.
Apps and channels of Clyzo
its YouTube channel Clyzo Online has 30 subscribers and 9 videos.
Videos from Clyzo
The most watched videos on Clyzo's YouTube channel, Clyzo Online (30 subscribers). Click a video to play it here.
More on Clyzo Online.
Board of directors of Pharmonix Biologicals Private Limited (Clyzo)
Pharmonix Biologicals Private Limited is the primary company behind Clyzo. The board of Pharmonix Biologicals Private Limited currently have 3 directors; the longest-serving is Payal Agarwal, appointed in 2018.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Payal Agarwal DIN 08088268 | Director | 16 Mar 2018 | 8 yrs 8 mo | Pharmonix Biologicals Private Limited |
| Sharad Kumar Agarwal DIN 07984332 | Director | 16 Mar 2018 | 8 yrs 8 mo | Pharmonix Biologicals Private Limited |
| Sunita DIN 10443222 | Director | 31 Jul 2024 | 2 yrs 3 mo | Pharmonix Biologicals Private Limited |
Financials of Clyzo
Figures of Pharmonix Biologicals Private Limited, the primary company behind Clyzo, for FY 2024. Revenue was ₹35.43 Cr (+26% year on year). Net profit was ₹6.30 Cr (18% margin). EBITDA was ₹8.81 Cr (25% margin). Revenue has grown at a compounded annual rate of -23% over three years and +40% over five years.
- ₹35.43 CrRevenue · FY 2024 · +26% YoY
- ₹6.30 CrNet profit · 18% margin
- ₹8.81 CrEBITDA · 25% margin
- ₹1 LakhPaid-up capital
- 20Employees (provident fund records)
- -23%Revenue CAGR, 3 years
- +40%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Pharmonix Biologicals Private Limited are on its company page.
Detailed financial statements for Clyzo
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Clyzo
Clyzo was founded in 2018.
Clyzo has 20 employees.
The primary company behind Clyzo, Pharmonix Biologicals Private Limited, reported revenue of βΉ35.43 Cr for FY 2024, up 26% year on year.
Clyzo is recognized as an innovative platform that facilitates the searching, sampling, quoting, and purchasing of over 7500 pharmacopoeial excipients. Access to 1800 rare excipients across 40 categories is provided, along with regulatory documents in one place to simplify vendor qualifications. The platform supports drug development by offering tools for faster formulations and value-added services like REGpro and FINDezy. Testimonials indicate that procurement processes are streamlined, reducing time and effort for users.
Clyzo offers Excipients and Value Added Services.
Clyzo operates through Pharmonix Biologicals Private Limited.
The legal entities of Clyzo currently have 3 directors, including Payal Agarwal, Sharad Kumar Agarwal, Sunita.